Literature DB >> 7288927

Fv-1 host restriction of Friend leukemia virus: analysis of unintegrated proviral DNA.

J Chinsky, R Soeiro.   

Abstract

The murine gene Fv-1 predominantly controls the outcome of infection by murine ecotropic retroviruses. The inhibition of virus replication by the Fv-1 gene product has been determined to be at an early stage in virus replication. Mechanistically, its effect appears to be on the accumulation of unintegrated proviral DNA or its integration or both. We investigated the synthesis of unintegrated proviral DNA, using several clones of B-, N-, or NB-tropic Friend murine leukemia virus. Our results indicate that the accumulation of B-tropic proviral DNA in NIH cells may be inhibited at either the level of linear (form III) or covalently closed circular DNA (form I), depending upon the degree of restriction of the clone of virus used. We confirmed that there is an effect of the Fv-1 gene on the accumulation of form I DNA of either B- or N-tropic Friend murine leukemia virus. However, the decrease in infectious centers effected by the Fv-1 gene did not correlate quantitatively with the effect on form I proviral DNA produced by N-tropic Friend murine leukemia virus in nonpermissive cells. Lastly, we demonstrated in nonpermissively infected NIH cells that a rapidly migrating doublet of viral DNA is formed.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7288927      PMCID: PMC256594          DOI: 10.1128/JVI.40.1.45-55.1981

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Replication kinetics of N- and B-tropic murine leukemia viruses on permissive and nonpermissive cells in vitro.

Authors:  A Declève; O Niwa; E Gelmann; H S Kaplan
Journal:  Virology       Date:  1975-06       Impact factor: 3.616

2.  A major genetic locus affecting resistance to infection with murine leukemia viruses. IV. Dose-response relationships in Fv-1-sensitive and resistant cell cultures.

Authors:  T Pincus; J W Hartley; W P Rowe
Journal:  Virology       Date:  1975-06       Impact factor: 3.616

3.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

4.  Selective extraction of polyoma DNA from infected mouse cell cultures.

Authors:  B Hirt
Journal:  J Mol Biol       Date:  1967-06-14       Impact factor: 5.469

5.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

6.  Growth of pseudotypes of vesicular stomatitis virus with N-tropic murine leukemia virus coats in cells resistant to N-tropic viruses.

Authors:  A S Huang; P Besmer; L Chu; D Baltimore
Journal:  J Virol       Date:  1973-09       Impact factor: 5.103

7.  Host restriction of Friend leukemia virus. Role of the viral outer coat.

Authors:  T G Krontiris; R Soeiro; B N Fields
Journal:  Proc Natl Acad Sci U S A       Date:  1973-09       Impact factor: 11.205

8.  Reciprocal inhibition of mouse leukemia virus infection by Fv-1 allele cell extracts.

Authors:  R W Tennant; B Schluter; W Yang; A Brown
Journal:  Proc Natl Acad Sci U S A       Date:  1974-10       Impact factor: 11.205

9.  Host-range restrictions of murine leukemia viruses in mouse embryo cell cultures.

Authors:  J W Hartley; W P Rowe; R J Huebner
Journal:  J Virol       Date:  1970-02       Impact factor: 5.103

10.  A major genetic locus affecting resistance to infection with murine leukemia viruses. I. Tissue culture studies of naturally occurring viruses.

Authors:  T Pincus; J W Hartley; W P Rowe
Journal:  J Exp Med       Date:  1971-06-01       Impact factor: 14.307

View more
  22 in total

1.  Development and characterization of an Fv-1-sensitive retrovirus-packaging system: single-hit titration kinetics observed in restrictive cells.

Authors:  L R Boone; C L Innes; P L Glover; E Linney
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

2.  Activated v-myc and v-ras oncogenes do not transform normal human lymphocytes.

Authors:  M Stevenson; D J Volsky
Journal:  Mol Cell Biol       Date:  1986-10       Impact factor: 4.272

3.  An X-linked gene affecting mouse cell DNA synthesis also affects production of unintegrated linear and supercoiled DNA of murine leukemia virus.

Authors:  A Richter; H L Ozer; L DesGroseillers; P Jolicoeur
Journal:  Mol Cell Biol       Date:  1984-01       Impact factor: 4.272

4.  Nucleotide sequences of gag-pol regions that determine the Fv-1 host range property of BALB/c N-tropic and B-tropic murine leukemia viruses.

Authors:  C Y Ou; L R Boone; C K Koh; R W Tennant; W K Yang
Journal:  J Virol       Date:  1983-12       Impact factor: 5.103

5.  Fv-1 host cell restriction of friend leukemia virus: microinjection of unintegrated viral DNA.

Authors:  J Chinsky; R Soeiro; J Kopchick
Journal:  J Virol       Date:  1984-04       Impact factor: 5.103

6.  Porcine endogenous retrovirus infects but does not replicate in nonhuman primate primary cells and cell lines.

Authors:  Armin Ritzhaupt; Luc J W Van Der Laan; Daniel R Salomon; Carolyn A Wilson
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

7.  Human immunodeficiency virus type 1 DNA synthesis, integration, and efficient viral replication in growth-arrested T cells.

Authors:  G Li; M Simm; M J Potash; D J Volsky
Journal:  J Virol       Date:  1993-07       Impact factor: 5.103

8.  A low oncogenic variant of Friend murine leukemia virus with strong immunosuppressive properties.

Authors:  A Faxvaag; H Y Dai; H Aarseth; A B Dalen
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

9.  Fv-1 restriction and its effects on murine leukemia virus integration in vivo and in vitro.

Authors:  P M Pryciak; H E Varmus
Journal:  J Virol       Date:  1992-10       Impact factor: 5.103

10.  Molecular cloning and characterization of an immunosuppressive and weakly oncogenic variant of Friend murine leukemia virus, FIS-2.

Authors:  H Y Dai; A Faxvaag; G I Troseth; H Aarset; A Dalen
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.